SEC Tracker
Get the app

Possible new BMRN shares

BMRNDilution

Known so far: no new shares from the prospectus covers read · no effective shelf · not yet read: warrants, options, ATM.

Shelf room

  • Room today none, no effective shelf
How this is worked out

Shelf room: none. No shelf registration on EDGAR was declared effective in the last 3 years, so a sale needs a new registration or a private placement. Sources: public float, as of Jun 30, 2025.

What could become new BioMarin Pharmaceutical (BMRN) shares: convertible notes, each with the 10-Q, 10-K, S-3 or 424B filing it comes from.

BMRN dilution ladder

Every source of new shares on record, from the filings that created it.

193.7M outstanding; up to 198.1M fully diluted, +2%

  1. Outstandingas of Oct 26, 2026 (10-Q filed Nov 3) · share count on the cover page
    193.7M
  2. Convertible notes4.4M shares10-Q Nov 3, 2026 · securities left out of diluted EPS
    +4.4M

Not stated in the filings we read: an ATM program, warrants, options and RSUs.

Counts, sizes and prices as stated in each filing; the fully diluted count is arithmetic on them. Dollars become shares only at a price a filing states. Not advice.

Shares outstanding

194M

Feb 2025 to Oct 2026: from 191M to 194M.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.